A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group
2012
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
ton University. The conference brought together leaders from academia, industry, and government to (1) discuss personalized medicine's current and potential impact on cardiovascular patient outcomes; (2) review emerging technologies and applications that may shape the field in the future; (3) discuss the results of an American College of Cardiology survey examining personalized medicine adoption rates among US cardiologists; (4) identify the barriers to adoption of pharmacogenetics-based
doi:10.1161/jaha.111.000554
pmid:23130127
pmcid:PMC3487365
fatcat:b67sxx5ryvbtzbum6wsxyg3k5e